Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bc6c2dc67b9ebc4cf31d9e226046f8c22> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bc6c2dc67b9ebc4cf31d9e226046f8c22 NCIT_P378 "NCI" @default.
- Bc6c2dc67b9ebc4cf31d9e226046f8c22 type Axiom @default.
- Bc6c2dc67b9ebc4cf31d9e226046f8c22 annotatedProperty IAO_0000115 @default.
- Bc6c2dc67b9ebc4cf31d9e226046f8c22 annotatedSource NCIT_C104744 @default.
- Bc6c2dc67b9ebc4cf31d9e226046f8c22 annotatedTarget "An orally available inhibitor of extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity. Upon oral administration, ulixertinib inhibits both ERK 1 and 2, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is often upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival." @default.